Innoviva, Inc. (INVA)
23.39
-0.25
(-1.06%)
USD |
NASDAQ |
Feb 20, 16:00
23.38
0.00 (0.00%)
After-Hours: 20:00
Innoviva Market Cap : 1.749B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 303.45B |
| Nektar Therapeutics | 1.276B |
| Regeneron Pharmaceuticals, Inc. | 82.43B |
| Oramed Pharmaceuticals, Inc. | 128.16M |
| Theravance Biopharma, Inc. | 996.22M |
Market Cap Related Metrics
| PE Ratio | 16.78 |
| PS Ratio | 4.598 |
| PEG Ratio | 0.1635 |
| Price to Book Value | 1.732 |
| Price to Free Cash Flow | 9.412 |
| Price | 23.39 |
| Earnings Yield | 5.96% |
| PEGY Ratio | 0.1635 |
| Operating PE Ratio | 11.02 |
| Normalized PE Ratio | 13.58 |